Robot-Guided brain zaps: a new hope for postpartum depression?

NCT ID NCT07757815

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study explores whether robot-guided repetitive transcranial magnetic stimulation (rTMS) can effectively treat postpartum depression (PPD). Researchers will compare brain activity, heart signals, blood markers, and body awareness in women with PPD versus healthy controls. Participants with PPD will receive 20 sessions of high-precision rTMS over 4 weeks, and the study will track whether certain biological markers can predict who responds best to treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Repetitive transcranial magnetic stimulation (rTMS) delivered with robot-guided precision
What this could lead to
If successful, this could lead to a more personalized, effective treatment for postpartum depression, using brain and body signals to guide therapy.
What could go wrong
This is an early-stage study, and the treatment may not work for everyone. rTMS can cause side effects like headache or scalp discomfort, and the biomarkers may not reliably predict response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION, POSTPARTUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kiang Wu Hospital

    Macao, 999078, Macau

  • the Center for Cognitive and Brain Sciences, Research Building N21

    Macao, 999078, Macau

More trials for these conditions

Other studies related to the condition(s) this trial covers.